Chitosan-Based Nano Systems for Natural Antioxidants in Breast Cancer Therapy

被引:21
作者
Herdiana, Yedi [1 ]
Husni, Patihul [1 ]
Nurhasanah, Siti [2 ]
Shamsuddin, Shaharum [3 ,4 ,5 ]
Wathoni, Nasrul [1 ]
机构
[1] Univ Padjadjaran, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, Sumedang 45363, Indonesia
[2] Univ Padjadjaran, Fac Agr Ind Technol, Sumedang 45363, Indonesia
[3] Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian 16150, Malaysia
[4] Univ Sains Malaysia, Inst Res Mol Med INFORMM, Nanobiotech Res Initiat, George Town 11800, Malaysia
[5] Univ Sains Malaysia, USM RIKEN Interdisciplinary Collaborat Adv Sci URI, George Town 11800, Malaysia
关键词
breast cancer; bioavailability; chitosan; oral drug delivery; pharmacokinetic; pharmacodynamic properties; OXIDATIVE STRESS; DRUG-DELIVERY; NANOPARTICLES; PHARMACOKINETICS; STRATEGIES; STABILITY; BIODEGRADATION; CHEMOTHERAPY; ENHANCE;
D O I
10.3390/polym15132953
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Breast cancer is a major cause of death globally, accounting for around 13% of all deaths. Chemotherapy, the common treatment for cancer, can have side effects that lead to the production of reactive oxygen species (ROS) and an increase in oxidative stress in the body. Antioxidants are important for maintaining the health of cells and helping the immune system function properly. They play a crucial role in balancing the body's internal environment. Using natural antioxidants is an alternative to mitigate the harmful effects of oxidative stress. However, around 80% of natural antioxidants have limited effectiveness when taken orally because they do not dissolve well in water or other solvents. This poor solubility affects their ability to be absorbed by the body and limits their bioavailability. One strategy that has been considered is to increase their water solubility to increase their oral bioavailability. Chitosan-based nanoparticle (CSNP) systems have been extensively explored due to their reliability and simpler synthesis routes. This review focuses on the various methods of chitosan-based nanoformulation for developing effective oral dosage forms for natural antioxidants based on the pharmacokinetics and pharmacodynamics properties. Chitosan (CS) could be a model, because of its wide use in polymeric NPs research, thus providing a better understanding of the role of vehicles that carry natural antioxidants in maintaining the stability and enhancing the performance of cancer drugs.
引用
收藏
页数:28
相关论文
共 50 条
  • [41] Chitosan-Based Thermoreversible Hydrogel as an in Vitro Tumor Microenvironment for Testing Breast Cancer Therapies
    Tsao, Ching-Ting
    Kievit, Forrest M.
    Wang, Kui
    Erickson, Ariane E.
    Ellenbogen, Richard G.
    Zhang, Miqin
    MOLECULAR PHARMACEUTICS, 2014, 11 (07) : 2134 - 2142
  • [42] Oral insulin delivery systems using chitosan-based formulation: a review
    Al Rubeaan, Khalid
    Rafiullah, Mohamed
    Jayavanth, Sanjay
    EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (02) : 223 - 237
  • [43] Advances in chitosan-based blends as potential drug delivery systems: A review
    Saadh, Mohamed J.
    Hsu, Chou-Yi
    Mustafa, Mohammed Ahmed
    Mutee, Ahmed Faisal
    Kaur, Irwanjot
    Ghildiyal, Pallavi
    Ali, Abdul-jabbar A.
    Adil, Mohaned
    Ali, Mohammed Shnain
    Alsaikhan, Fahad
    Narmani, Asghar
    Farhood, Bagher
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 273
  • [44] Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects
    Saheb, Mahsa
    Fereydouni, Narges
    Nemati, Saeideh
    Barreto, George E.
    Johnston, Thomas P.
    Sahebkar, Amirhossein
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 12325 - 12340
  • [45] Advances in Chitosan-based Drug Delivery Systems in Melanoma: A Narrative Review
    Dana, Parisa Maleki
    Hallajzadeh, Jamal
    Asemi, Zatollah
    Mansournia, Mohammad Ali
    Yousefi, Bahman
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (23) : 3488 - 3501
  • [46] Smart Drug Delivery Systems Based on Cyclodextrins and Chitosan for Cancer Therapy
    Paduraru, Larisa
    Panainte, Alina-Diana
    Peptu, Catalina-Anisoara
    Apostu, Mihai
    Vieriu, Madalina
    Bibire, Tudor
    Sava, Alexandru
    Bibire, Nela
    PHARMACEUTICALS, 2025, 18 (04)
  • [47] CHITOSAN-BASED BIONANOCOMPOSITE FOR TRANSDERMAL THERAPY
    Aflori, Magdalena
    Spiridon, Maria
    Butnaru, Maria
    Mandru, Mihaela
    Romila, Laura
    Daraba, Oana
    Burlui, Alexandra
    INTERNATIONAL JOURNAL OF MEDICAL DENTISTRY, 2019, 23 (01) : 40 - 45
  • [48] Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer's Disease Therapy
    Georgieva, Dilyana
    Nikolova, Denitsa
    Vassileva, Elena
    Kostova, Bistra
    PHARMACEUTICS, 2023, 15 (03)
  • [49] Exploring the current landscape of chitosan-based hybrid nanoplatforms as cancer theragnostic
    Nair, Rahul
    Paul, Priti
    Maji, Indrani
    Gupta, Ujala
    Mahajan, Srushti
    Aalhate, Mayur
    Guru, Santosh Kumar
    Singh, Pankaj Kumar
    CARBOHYDRATE POLYMERS, 2024, 326
  • [50] Stimuli-responsive hydrogel based on natural polymers for breast cancer
    Asadi, Khatereh
    Samiraninezhad, Nazafarin
    Akbarizadeh, Amin Reza
    Amini, Abbas
    Gholami, Ahmad
    FRONTIERS IN CHEMISTRY, 2024, 12